As a result of the collaboration over recent years, a functional group has emerged with joint collaboration lines focused on molecular imaging, drug development, and pharmacokinetics. The current infrastructures, knowledge, and platforms have led to a unique synergy capable of providing the best possible assistance and research in the field of personalized medicine.